Clinical
RSSArticles
-
Clinical Briefs
In this section: a connection between atopic dermatitis and autoimmune disorders; association of sickle cell trait with hemoglobin; and the continuing search for dementia triggers.
-
Naldemedine Tablets (Symproic) C-II
Naldemedine is indicated for the treatment of opioid-induced constipation in adults with chronic noncancer pain.
-
Vitamin D to Prevent Acute Respiratory Infections?
Vitamin D supplementation is associated with a decreased risk of respiratory infections, especially in those who had low circulating levels of 25-hydroxyvitamin D.
-
Migraine: Differences Between Males and Females
Hormonal and genetic differences factor into a greater prevalence and disability burden of migraine in teenaged girls and women; however, migraine is underdiagnosed and inadequately treated in boys and men.
-
Troponin Highly Prognostic in Decompensated Heart Failure With Preserved Ejection Fraction
Among patients with acute decompensated heart failure and preserved ejection fraction, elevated troponin is associated with worse in-hospital outcomes and long-term survival, independent of other predictors.
-
Abortion for Fetal Anomalies: Trends in Gestational Age
In this retrospective cohort study, the median gestational age at the time of abortion for fetal aneuploidy decreased from 19 weeks in 2004 to 14 weeks in 2014. However, the gestational age at the time of abortion for fetal structural abnormalities remained at ≥ 20 weeks over the study period.
-
Preparation for the Next Pregnancy
This special feature addresses ways a woman can optimize outcomes in her next pregnancy by following specific preparatory activities during her interpregnancy interval.
-
Contraception: More Effective Than Ever?
A new analysis from the National Survey of Family Growth demonstrates a decrease from 12% in 2002 to 10% in 2006-2010 in the overall rate of failure among women using reversible methods of contraception.
-
Nocturnal Enuresis: Are Your Patients Affected?
Nocturnal enuresis was prevalent in women seen in a urogynecology setting and can be associated with nocturia, overactive bladder symptoms, and stress incontinence.
-
FDA Actions
In this section: The agency approves exciting new treatment for multiple sclerosis, green lights an injection for atopic dermatitis, gives the go ahead to an add-on treatment for Parkinson's disease, and signs off on a drug for Duchenne muscular dystrophy.